PRESCRIBING · PART D · 2024
Total Rx claims
967
Beneficiaries
—
Total drug cost
$990K
Distinct drugs
28
Brand share
23.5%
Top prescribed drugs
Gabapentin128 claims
Baclofen115 claims
Tizanidine Hcl91 claims
Teriflunomide51 claims
Dalfampridine48 claims
QUALITY · MIPS · 2024
Final MIPS score
81.1
Quality
63.3
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.26%
Group
CROSS-REFERENCE